Compound
Active ingredients:
affinity purified antibodies to human interferon gamma – 10,000 EMD*,
affinity purified antibodies to histamine – 10,000 EMD*,
affinity purified antibodies to CD4 – 10,000 EMD*.

Indications
Treatment of influenza and acute respiratory viral infections (ARVI) in adults and children over 6 months of age.
Treatment of acute intestinal infections of viral etiology (ACVI) in adults and children over 6 months of age.
Nonspecific prevention of COVID-19 during the period of vaccination between the introduction of the first and second components of the vaccine against a new coronavirus infection in adults.

Use during pregnancy and breastfeeding
The safety of Ergoferon® in pregnant women has not been studied.
During pregnancy and lactation, the drug is used only if the expected benefit to the mother outweighs the potential risk to the fetus and child. The benefit-risk ratio is determined by the attending physician.

Contraindications
Increased individual sensitivity to the components of the drug.
Lactase deficiency, hereditary galactose intolerance, glucose-galactose malabsorption.
Children up to 6 months of age - for the treatment of influenza, ARVI and ARVI.
Children under 18 years of age - for nonspecific prevention of COVID-19 during the period of vaccination between the introduction of the first and second components of the vaccine against a new coronavirus infection.

Side effects
Individual hypersensitivity reactions to the components of the drug are possible. If you experience any unwanted reactions listed in the instructions or they get worse, or you notice any other unwanted reactions not listed in the instructions, tell your doctor.

Storage conditions
At a temperature not higher than 25 °C.
Keep out of the reach of children.

Best before date
3 years.
Do not use after the expiration date.